Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPIONE 2: Tradipitant in Atopic Dermatitis
NCT04140695Phase 3Terminated
- Sponsor
- Vanda Pharmaceuticals Inc.
- Start
- Oct 2019
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tradipitant in atopic dermatitis (AD), sponsored by Vanda Pharmaceuticals Inc.. Started Oct 2019; status: terminated.
02
Drugs
tradipitant
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT04140695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04140695.